Prescribing patterns of medicines in chronic kidney disease patients on maintenance hemodialysis

被引:20
|
作者
Chakraborty, Sourav [1 ]
Ghosh, Saugata [1 ]
Banerjea, Avishek [1 ]
De, Radha Raman [1 ]
Hazra, Avijit [3 ]
Mandal, Swapan Kumar [2 ]
机构
[1] RG Kar Med Coll, Dept Pharmacol, Kolkata, W Bengal, India
[2] RG Kar Med Coll, Dept Hemodialysis, Kolkata, W Bengal, India
[3] IPGMER, Dept Pharmacol, Kolkata, W Bengal, India
关键词
Chronic kidney disease; diabetic nephropathy; hemodialysis; medication adherence; prescribing patterns; DIABETIC-NEPHROPATHY; PHOSPHATE BINDERS; RRI-CKD; MORTALITY; BURDEN; HYPERNATREMIA; PRESCRIPTION; HYPOGLYCEMIA; POTASSIUM; ADHERENCE;
D O I
10.4103/0253-7613.190760
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To study medicine prescribing pattern for chronic kidney disease (CKD) patients on maintenance hemodialysis. Materials and Methods: This prospective observational study was conducted in hemodialysis unit of a teaching hospital with adult CKD patients on maintenance hemodialysis. Patients' clinical profile, drug-use pattern, and medication-related problem data were captured in a structured case report form and the data were analyzed descriptively. Adherence level was assessed by Morisky Medication-Taking Adherence Scale 4-item. Results: Data from 100 patients recruited over 6 months have been analyzed. The median (interquartile range [IQR]) age was 51 (42-57) years; 57% were male, mean [standard deviation (SD)] urea level was 160.11 (70.32) mg/dL, mean (SD) creatinine level was 8.73 (5.29) mg/dL. A large number (46%) were suffering from diabetic nephropathy. The common comorbidities were anemia (89%) followed by hypertension (85%). The median (IQR) number of drugs per prescription was 10 (9-13), with the bulk being cardiovascular drugs (23.41%) followed by gastrointestinal drugs (15.76%) and vitamins (12.29%). The median (IQR) number of potential drug-drug interaction per prescription was 2 (2-3). The incidence of adverse drug reactions (ADRs) was 46% with hyponatremia being most common (32%), followed by hypoglycemia (16%) and hypokalemia (10%). Adherence level was low in the majority (64%) of patients. Conclusions: There is a high incidence of polypharmacy along with significant medication-related problems such as high drug-drug interactions/prescription, high incidence of ADRs, and low adherence.
引用
收藏
页码:586 / 590
页数:5
相关论文
共 50 条
  • [41] Platelet reactivity in patients with chronic kidney disease and hemodialysis
    Mourikis, Philipp
    Helten, Carolin
    Dannenberg, Lisa
    Hohlfeld, Thomas
    Stegbauer, Johannes
    Petzold, Tobias
    Levkau, Bodo
    Zeus, Tobias
    Kelm, Malte
    Polzin, Amin
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (01) : 168 - 172
  • [42] Vitamin C in chronic kidney disease and hemodialysis patients
    Deicher, R
    Hörl, WH
    KIDNEY & BLOOD PRESSURE RESEARCH, 2003, 26 (02): : 100 - 106
  • [43] Efficacy of Roxadustat Combined with rhEPO on Renal Anemia during Maintenance Hemodialysis in Chronic Kidney Disease Patients
    Zhang, Xiaoli
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (06): : 1354 - 1358
  • [44] FLUID OVERLOAD AND DIURETICS PRESCRIBING IN CHRONIC KIDNEY DISEASE PATIENTS
    Khan, Y. H.
    VALUE IN HEALTH, 2018, 21 : S69 - S69
  • [45] Diets for patients with chronic kidney disease, still worth prescribing
    Mitch, WE
    Remuzzi, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : 234 - 237
  • [46] Herbal medicines and chronic kidney disease
    Jha, Vivekanand
    NEPHROLOGY, 2010, 15 : 10 - 17
  • [47] Medication-prescribing patterns of primary care physicians in chronic kidney disease
    Morishita, Yoshiyuki
    Numata, Akihiko
    Miki, Atushi
    Okada, Mari
    Ishibashi, Kenichi
    Takemoto, Fumi
    Ando, Yasuhiro
    Muto, Shigeaki
    Kusano, Eiji
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (05) : 690 - 696
  • [48] Medication-prescribing patterns of primary care physicians in chronic kidney disease
    Yoshiyuki Morishita
    Akihiko Numata
    Atushi Miki
    Mari Okada
    Kenichi Ishibashi
    Fumi Takemoto
    Yasuhiro Ando
    Shigeaki Muto
    Eiji Kusano
    Clinical and Experimental Nephrology, 2014, 18 : 690 - 696
  • [49] Bisphosphonate prescribing in chronic kidney disease
    Courtney, A. E.
    Leonard, N.
    McCloskey, M. C.
    Smyth, J. S.
    Maxwell, A. P.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2009, 39 (01): : 4 - 9
  • [50] Prescribing and deprescribing in chronic kidney disease
    Manski-Nankervis, Jo-Anne
    McMorrow, Rita
    Nelson, Craig
    Jesudason, Shilpanjali
    Sluggett, Janet K.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2021, 50 (04) : 183 - 187